J.P. Marvel Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.1M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$29.9M |
| 3 |
Amazon
AMZN
|
+$23M |
| 4 |
Bank of America
BAC
|
+$12.8M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$10.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$5.49M |
| 2 |
Newmont
NEM
|
+$2.82M |
| 3 |
Franco-Nevada
FNV
|
+$1.12M |
| 4 |
Wheaton Precious Metals
WPM
|
+$935K |
| 5 |
Dell
DELL
|
+$623K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.37% |
| 2 | Technology | 26.7% |
| 3 | Financials | 12.95% |
| 4 | Communication Services | 7.46% |
| 5 | Consumer Discretionary | 7.09% |
Similar funds
J.P. Marvel Investment Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, J.P. Marvel Investment Advisors held 73 positions worth $512M, up 54% from $332M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
J.P. Marvel Investment Advisors deployed $148M of net new capital in Q4 2021, opening 16 new positions and adding to 12 existing holdings. Its largest new stake was Apple: 215,704 shares worth $38.3M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 38% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Moderna, an estimated $5.49M trimmed.
- J.P. Marvel Investment Advisors's largest Q4 2021 buy was Apple: 215,704 shares worth $38.3M.
- J.P. Marvel Investment Advisors added most to Pfizer in Q4 2021, an estimated $769K increase.
- J.P. Marvel Investment Advisors's biggest Q4 2021 reduction was Moderna, cutting an estimated $5.49M.
- J.P. Marvel Investment Advisors fully exited Newmont in Q4 2021, selling an estimated $2.82M.
- J.P. Marvel Investment Advisors's ten largest holdings make up 44% of its $512M portfolio in Q4 2021.
- J.P. Marvel Investment Advisors opened 16 new positions and closed 3 in Q4 2021.
- J.P. Marvel Investment Advisors's portfolio value rose 54% quarter-over-quarter to $512M.
Based on J.P. Marvel Investment Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.